A Study on the Role of Thrombophilic Genetic Disorders as a Risk Factor for Thrombotic Complications in Patients with Myeloproliferative Disorders

Doroteya K. Todorieva-Todorova; Katya S. Kovacheva; Nikolay T. Tzvetkov; Stefan V. Trifonov; Galya Ts. Stavreva; Tihomir R. Rashev; Alexander A. Todorov; Petar D. Ivanov

doi:10.2478/jbcr-2019-0003

Abstract

Myeloproliferative neoplasms (MPN) are haematological diseases, characterized by clonal hematopoiesis. Hemostasis abnormalities are among the most critical and frequent complications, affecting the quality of life and a possible reason for death. Thrombotic complications are common and multifactorial. Our aim was to study some genetic thrombophilia factors – Factor V Leiden (FVL), G20210A mutation in prothrombin gene (PR G20210A) and PLA2 allele polymorphism of glycoprotein IIIa gene (GPIIIa gene), and their frequency and association with thrombotic risk in both Philadelphia-positive and Philadelphia-negative MPN – chronic myelogenous leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), and primary and secondary myelofibrosis (MF). In our patient population, PLA2 allele polymorphism of GPIIIa gene proved to be the most common and significantly associated with thrombotic complications – 26.85% of our patients were carriers, and 24.14% of them reported thrombotic complications.

References

1. Gercheva-Kyuchukova L. [Chronic myeloproliferative neoplasms]. 1st ed. Pleven: Peychinski. 2016. Bulgarian.
Search in Google Scholar Back to article
2. Lutzkanova E, Marinova I, Pavlova D, Todorov V, Tzvetkov N. [Hematology]. In: Internal diseases part II – medical student book. 1st ed. Pleven: Medical University; 2012, p. 320-34. Bulgarian.
Search in Google Scholar Back to article
3. Aftab A, Naghmi A, Hassan K. Portal vein thrombosis in a case of chronic myeloid leukemia – a rare association. JIMDC.2013;2(4):87-9.
Search in Google Scholar Back to article
4. Jain A, Gupta N, Singh T, Agarwal S. A study of haemostatic parameters in patients of chronic myeloid leukaemia. J Clin Diagn Res. 2016;10(7):0C19-0C23.
Search in Google Scholar Back to article
5. Sora F, Iurlo A, Sica S, Latagliata R, Annunziata M, Galimberti S, et al. Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome. Br J Haematol. 2018;181(2):267-70.10.1111/bjh.1455328169426
Search in Google Scholar Back to article
6. Lad DP, Jain A, Varma S. Complications and management of coagulation disorders in leukemia patients. Dovepress. 2017;7:61-72.10.2147/BLCTT.S125121646734331360085
Search in Google Scholar Back to article
7. Elliott MA, Tefferi A. Thrombosis and hemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2004;128(3):275-90.10.1111/j.1365-2141.2004.05277.x
Search in Google Scholar Back to article
8. Sykes TC, Fegan C, Mosquera D. Thrombophilia, polymorphisms, and vascular disease. Mol Pathol. 2000;53(6):300-6.10.1136/mp.53.6.300118698411193048
Search in Google Scholar Back to article
9. Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica. 2002;87(10):1095-108.
Search in Google Scholar Back to article
10. Foy P, Moll S. Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med. 2009;11(2):114-28.10.1007/s11936-009-0012-x19289024
Search in Google Scholar Back to article
11. Kottke-Marchant K. Genetic polymorphisms associated with venous and arterial thrombosis. Arch Pathol Lab Med. 2002;126(3):295-304.10.5858/2002-126-0295-GPAWVA11860303
Search in Google Scholar Back to article
12. Antonov A, Kovacheva K, Ivanov P, Tsvetkov N, Komsa-Penkova R, Slavcheva V, et al. Genetic thrombophilic defects and risk of thrombotic complications in patients with essential thrombocythemia and polycythemia vera Part II. Contribution of the genetic thrombophilic defects to the thrombotic risk [Internet] [cited 2019 Jun 24]. Available at: https://www.researchgate.net/publication/290579253
Search in Google Scholar Back to article
13. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-20.10.1111/j.1365-2141.2009.08022.x20128794
Search in Google Scholar Back to article
14. Maidstone and Tunbridge Wells NHS. Guidelines for thrombophilia testing. [Internet]. [cited 2019 Jun 20]. Available from: https://www.mtw.nhs.uk/wp-content/uploads/2015/09/Guidelines-for-Thrombophilia-Testing1.pdf
Search in Google Scholar Back to article
15. Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Michael Streiff, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41(1):154-64.10.1007/s11239-015-1316-1471584026780744
Search in Google Scholar Back to article
16. Voelkerding KV, Wu L, Williams EC, Hoffman SM, Sabatini LM, Borcherding WR, et al. Factor V R506Q gene mutation analysis by PCR-RFLP – optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls. Am J Clin Pathol. 1996;106(1):100-6.10.1093/ajcp/106.1.1008701917
Search in Google Scholar Back to article
17. Jebeleanu G, Procopciuc L. G20210A prothrombin gene mutation identified in patients with venous leg ulcers. J Cell Mol Med. 2001;5(4):397-401.10.1111/j.1582-4934.2001.tb00174.x674025412067473
Search in Google Scholar Back to article
18. Potapov EV, Ignatenko S, Nasseri BA, Loebe M, Harke C, Bettmann M, et al. Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support. Ann Thorac Surg. 2004;77(3):869-74.10.1016/j.athoracsur.2003.08.01314992889
Search in Google Scholar Back to article
19. Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res. 1997;33(3):693-7.10.1016/S0008-6363(96)00222-2
Search in Google Scholar Back to article
20. Khan S. Dickerman JA. Hereditary thrombophilia. Thromb J. 2006;4(15):1-17.10.1186/1477-9560-4-15
Search in Google Scholar Back to article
21. Bertina RM. Factor V Leiden and other coagulation risk factor mutations affecting thrombotic risk. Clin Chem. 1997;43(9):1678-83.10.1093/clinchem/43.9.1678
Search in Google Scholar Back to article
22. Zoeller B, Andreas H, García de Frutos P, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70.
Search in Google Scholar Back to article
23. Hoerl HD, Tabares A, Kottke-Marchant K. The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature. Vasc Med. 1996. 1(4):275-80.10.1177/1358863X9600100406
Search in Google Scholar Back to article
24. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346(8983):1133-4.10.1016/S0140-6736(95)91803-5
Search in Google Scholar Back to article
25. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7.10.1038/369064a08164741
Search in Google Scholar Back to article
26. Jensen MK, de Nully Brown P, Thorsen S, Hasselbalch HC. Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders. Am J Hematol. 2002;69(3):185-91.10.1002/ajh.1005411891805
Search in Google Scholar Back to article
27. Trifa AP, Cucuianu A, Popp RA, Coada CA, Costache RM, Militaru MS, et al. Therelationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia. Ann Hematol. 2014;93(2):203-910.1007/s00277-013-1838-623828072
Search in Google Scholar Back to article
28. Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, et al. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Am J Hematol. 2002;71(1):1-6.10.1002/ajh.1015312221665
Search in Google Scholar Back to article
29. Afshar-Kharghan V, López JA, Gray LA, Padilla A, Borthakur G, Roberts SC, et al. Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia. Blood Coagul Fibrinolysis. 2004;15(1):21-4.10.1097/00001721-200401000-0000415166939
Search in Google Scholar Back to article
30. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79(4):706-8.10.1055/s-0037-1615049
Search in Google Scholar Back to article
31. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, et al. Prevalence of the 20210A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost. 1998;80(1):49-51.10.1055/s-0037-1615137
Search in Google Scholar Back to article
32. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005, 1-12.10.1182/asheducation.V2005.1.1.1
Search in Google Scholar Back to article
33. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698-703.10.1182/blood.V88.10.3698.bloodjournal88103698
Search in Google Scholar Back to article
34. Gisslinger H, Müllner M, Pabinger I, Heis-Vahidi-Fard N, Gisslinger B, Brichta A, et al. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study. Haematologica. 2005;90(3):408-10.
Search in Google Scholar Back to article
35. Bray PF. Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost. 1999. 82(2):337-44.10.1055/s-0037-1615851
Search in Google Scholar Back to article
36. Burr D, Doss H, Cooke GE, Goldschmidt-Clermont PJ. A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease. Stat Med. 2003;22(10):1741-60.10.1002/sim.137512720308
Search in Google Scholar Back to article

A Study on the Role of Thrombophilic Genetic Disorders as a Risk Factor for Thrombotic Complications in Patients with Myeloproliferative Disorders

Abstract

Paradigm

My account